Trial Outcomes & Findings for Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT NCT00903396)
NCT ID: NCT00903396
Last Updated: 2017-11-24
Results Overview
TERMINATED
PHASE2
7 participants
Up to 2 years
2017-11-24
Participant Flow
Participant milestones
| Measure |
Arm I
Patients receive palonosetron hydrochloride IV on day 1.
palonosetron hydrochloride: Given IV
|
Arm II
Patients receive palonosetron hydrochloride IV on days 1 and 4.
palonosetron hydrochloride: Given IV
|
Arm III
Patients receive placebo IV on day 1.
placebo: Given IV
|
Arm IV
Patients receive placebo IV on days 1 and 4.
placebo: Given IV
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
2
|
1
|
3
|
1
|
|
Overall Study
COMPLETED
|
2
|
1
|
3
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: Up to 2 yearsPopulation: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 2 yearsPopulation: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 2 yearsPopulation: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 2 yearsPopulation: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 2 yearsPopulation: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
Outcome measures
Outcome data not reported
Adverse Events
Arm I
Arm II
Arm III
Arm IV
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place